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Abstract: 
Background and aim: Local hemodynamic changes are one of the main factors that determines the 
vessel wall biological response after stent/scaffold implantation. Computational fluid dynamic studies 
provide an opportunity to investigate the rheological effects of implanted stent/scaffold. The aim of 
this study was to assess the local flow hemodynamic microenvironment in scaffolded segments in 
porcine coronary models. 
Methods: In 6 epicardial coronary arteries of  healthy mini-pigs, 6 Absorb bioresorbable vascular 
scaffolds (Absorb BVS) were implanted. Optical coherence tomography (OCT) was performed after 
scaffold implantation and the images were fused with the angiographic data to reconstruct the three 
dimensional coronary artery anatomy. Blood flow simulations were performed and endothelial shear 
stress (ESS) distribution was estimated for each scaffolded segment. In a linear mixed-effect model, 
the contributing factors for low (<1.0 Pa) ESS levels were assessed. At 30-day post-implantation, 
histopathological assessment was performed at 2 scaffold. 
Results: In scaffolded segments, the median ESS was 0.57 (IQR: 0.29-0.99) Pa.  In linear mixed-effect 
analysis, cross-section area was associated with low shear stress levels. In scaffolded segments, the 
percentage of the recirculation zones per scaffolded luminal surface was 3.26±2.07%. At 30-day 
histopathological assessment of implanted vessel segments revealed minimal injury score, minimal 
neointimal inflammation and minimal adventitial inflammation scores with moderate  endothelial 
coverage. Fibrin accumulation were seen at 95.69 ± 2.47% of the struts.  
Conclusion: The thick rectangular strut design of the Absorb BVS incited flow disruptions with  low 
shear stress inducing fibrin accumulation. CFD assessment can be used to guide improvements in the 
scaffold design for a more “hemo-compatible” geometry. 
Key words: Endothelial shear stress; bioresorbable scaffold; computational fluid dynamic  
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Introduction: 
Bioresorbable scaffold (BRS) has been introduced to overcome the drawbacks of metallic 
drug-eluting stents such as late stent thrombosis-due to delayed/incomplete healing-, 
neoatherosclerotic lesion development, and permanent metallic caging engenders abnormal vessel wall 
physiology(1). Stent/scaffold implantation induces crucial changes in local hemodynamic 
microenvironment in the treated vessel segment that greatly influences the reaction of the vessel wall 
(2). Stent design was shown one of the factors related with the in-stent restenosis in coronaries 
implanted with variety of stent types (3). 
Endothelial shear stress (ESS) appears an important conducive factor for the vessel wall 
response after stent/scaffold implantation (3). With its high resolution, optical coherence tomography 
(OCT) based in silico fluid dynamic models provide unique opportunity to study the effects of 
intracoronary stent/scaffold on the hemorheological changes in microenvironment(4). Following 
stent/scaffold implantation, computational fluid dynamic (CFD) studies have revealed disruptions in 
laminar flow and local alterations in ESS that can predispose the treated segments to platelet activation, 
intimal hyperplasia and as a consequence, thrombosis and in-stent re-stenosis(4). 
Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa. Clara, 
California, USA) is the first commercially-available BRS and has a long list of investigations. 
Following the Absorb scaffold implantation in diseased coronaries, lower ESS was shown to induce 
neointimal thickening during follow up (4). In the present exploratory study, we aimed at revealing the 
effect of device geometry and strut design on ESS distribution in Absorb BVS implanted vessel 
segments without any atherosclerotic disease in porcine coronary models. 
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Methods: 
Six Yucatan mini-swine pigs with healthy coronaries underwent percutaneous coronary 
intervention (PCI) via femoral access through a standard procedure(5). Overall, six Absorb BVS were 
implanted in 6 coronary arteries. The treated coronary arteries were studied by OCT imaging following 
the scaffold implantation. The animal study protocol was approved by the Institutional Animal Care 
and Use Committee and the study was conducted in accordance with the American Heart Association 
guidelines for preclinical research and the Guide for the Care and Use of Laboratory Animals(6). 
Device description: 
Absorb BVS is made of poly L-lactic acid (PLLA), coated with a layer of a 1:1 mixture of an 
amorphous matrix of poly D,L-lactic acid (PDLLA) and elutes everolimus (8.2 µg/mm). Absorb BVS, 
which is manufactured using extrusion and laser machining techniques, has 157µm strut thickness and 
a design of in-phase zig-zag hoops linked with bridges (Figure-1). 
Data acquisition: 
Coronary angiography was performed using Siemens HiCor cardiac angiography system 
(Siemens, Erlangen, Germany). The treated vessel segments were scrutinized using a frequency-
domain OCT system (C8-XR OCT Intravascular Imaging System; St. Jude Medical, St. Paul, MN, 
USA) that was pulled-back at a speed of 18 mm/sec. A non-occlusive flushing technique was used for 
blood clearance by injection of contrast media. The acquired data were stored in DICOM format and 
transferred to a workstation for further analysis. 
Coronary artery reconstruction: 
Coronary artery reconstruction was implemented using a well-established and validated 
methodology (7). In x-ray angiographic and OCT images, the radiopaque markers and the anatomical 
landmarks (i.e. side branches), identified both on angiography and OCT, were used to define the 
scaffolded segment and proximal-distal native vessel segments. 
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In the segment of interest, the OCT images portraying the scaffolded and the native vessel 
were identified and analyzed at a 0.1 mm interval in the scaffolded segment and a 0.2 mm interval in 
the native vessel segment. The flow area -defined in the native segment by the lumen border and in the 
scaffolded segment by the adluminal side of the scaffold struts and by the luminal surface in the inter-
strut areas(8)- was then delineated. 
Two post-procedure end-diastolic angiographic images with at least 30º-angle difference 
illustrating the segment of interest with minimal foreshortening were selected with the table in the 
isocenter. In these images, the luminal borders were detected for the segment of interest and used to 
extract the luminal centerline which was then used to define the 3D luminal centerline of the segment 
of interest(7). The flow area borders detected on OCT images were then superimposed perpendicularly 
onto the luminal centerline and anatomical landmarks, that is side-branches seen in both OCT and 
angiographic images were used to define the absolute orientation of the OCT frames(7).  
Blood flow simulation: 
The reconstructed 3D geometries were processed with CFD techniques. After finite volume 
mesh generation, blood flow was simulated and the ESS was estimated by solving the 3D Navier-
Stokes equations (ANSYS Fluent, Canonsburg, Pennsylvania) (9). In order to evaluate the impact of 
the scaffold design on the local hemodynamic micro-environment, the mesh density around the 
scaffold struts and within the boundary layer of the flow field at inter-strut area was increased to have 
an average element edge of 30 µm (equal to 0.25 of the thickness of the scaffold strut). Blood was 
assumed to be a homogeneous, Newtonian fluid with a viscosity of 0.0035 Pa.s and a density of 1,050 
kg/m3. At the inflow of the 3D CFD model, a steady flow profile was simulated. As shown in previous 
publications, no significant differences exist between the ESS estimated in pulsatile and steady flow 
simulation(10,11). For each reconstruction, blood flow was estimated by measuring, in the 2 
angiographic projections, the number of frames required for the contrast agent to pass from the inlet to 
the outlet of the reconstructed segment, the volume of the reconstructed segment and the cine frame 
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rate(3, 12). The arterial wall was considered to be rigid, consistent with what is expected post-
implantation. No-slip conditions were applied to the scaffold surface. At the outlet of the model, zero 
pressure conditions were applied. ESS at the luminal surface was calculated as the product of blood 
viscosity and the gradient of blood velocity at the wall(13). The ESS was measured in the native and 
the scaffolded segments around the circumference of the lumen at a 5° interval (sector) and along the 
axial direction at a 0.2 mm interval with the use of an in-house algorithm(4) (Figure 2). The 
recirculation zones in the vicinity of the struts were quantified based on the direction of the ESS vector 
and the centerline vector. Areas where the ESS vector had opposite direction to the centerline vector 
were considered to be exposed to recirculation.   
Histopathological analysis: 
Two animals from the study population were humanely euthanized for histopathological 
assessment at 30-day post-implantation. Other animals left for histological analysis at 180-days, 360-
days and 720-days post-implantation. Each of sacrificed animal had 1 implanted Absorb BVS. One 
Absorb BVS (Absorb BVS-6, 3.0x 18 mm) was implanted in the RCA of the first animal, and the other 
one (Absorb BVS-2, 3.0x18mm) was implanted in the LCx of the second animal. Sections from the 
proximal, mid and distal portions of each scaffolded segments were cut on a rotary microtome at six 
microns, mounted and stained with hematoxylin and eosin (H&E) and Movat pentachrome stains. All 
sections (n=6) were examined by light microscopy for the presence of inflammation, thrombus, and 
vessel wall injury. The cross-sectional areas (external elastic lamina [EEL], internal elastic lamina 
[IEL], and lumen) of each scaffolded section were measured. Neointimal thickness was measured as 
the distance from the inner surface of each scaffold strut to the luminal border. Area measurements 
were used to calculate vessel layer areas with the following formulas: Medial Area = EEL Area- IEL 
Area, Neointimal Area = IEL Area- Lumen Area, % Stenosis = [1- (Lumen Area / IEL Area)] x 100. 
To compare neointimal organization and healing, data were collected on each scaffold section 
including, strut apposition to the vessel wall, fibrin deposition, calcification, granuloma and giant cell 
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reactions and hemorrhage around the scaffold struts and was expressed as a percentage of the total 
number of struts in each section. A vessel injury score was calculated according to the Schwartz 
method (14). An overall neointimal inflammation (score 0-4) and adventitial inflammation (score 0-3) 
and fibrin value (score 0-3) were scored for each section. Scaffolded vessels with two or more 
granulomatous reactions around the scaffold struts in any section were assigned a neointimal 
inflammation “grade 4”. A description of these scores is demonstrated in Table 1. Endothelial 
coverage was estimated and expressed as the percentage of the lumen circumference covered by 
endothelium. 
Statistical analysis: 
Continuous variables were tested for normality of distribution with Kolmogorov-Smirnov test 
and are presented as mean ± SD or median (interquartile range) as appropriate. Categorical variables 
are presented as frequencies and percentages. Continuous variables were compared by the Kruskal-
Wallis test or Mann Whitney U test. Categorical variables were compared by the Pearson Chi-square 
test.   
There were several layers of grouping within the data of the study; six animals (level 4) 
received scaffold implants in up to three different arteries (level 3), where only one scaffold was 
implanted in each artery. Each scaffolded segment has several cross-sections (level 2) and each 
circumferential contour was divided into 72 sectors (5º-subunits) (level 1) in which ESS was measured. 
As the data in the study have multi-level structure and unbalanced design, mixed effects models were 
used to analyze the data. Since the ESS data have a skewed distribution, square root transformations 
of the ESS data were performed to get a normal distribution for ESS data. The multi-level model was 
built with fixed effects on cross-sectional area, vessel type and the 5-degree subunits and random 
effects on animal ID, vessel type and cross-section ID. All computations were done using the statistical 
analysis program SPSS V.22, R V. 3.2.3(15) and the R package lme4(16). 
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Results: 
In the study animals (n=6), one left anterior descending artery (LAD), 3 left circumflex arteries 
(LCx) and 2 right coronary arteries (RCA) were treated. All scaffolds were well-apposed to the vessel 
wall and there were no malapposed struts. The list of scaffold diameters, lengths, deployment 
pressures, post-implantation dilatation balloon pressures, post-implantation scaffold diameters and the 
implantation locations in the treated  coronaries are shown in Table-2. The median ESS values and 
dimensions of the proximal non-scaffolded segment, scaffolded segment and the distal non-scaffolded 
segment are shown in Table-3.  
In scaffolded segments, the median ESS was 0.57 (interquartile range [IQR]: 0.29-0.99) Pa. 
The histogram of ESS for the Absorb BVS (Figure 3) showed that, 75% of the scaffolded surface was 
exposed to a low (<1 Pa), athero-promoting ESS environment (Figure-4). The mean percentage of 
recirculation area per scaffolded vessel segment surface area was 3.26±2.07% (Figure-5). After setting 
the model with random and fixed effects variables, multi-level linear regression analysis revealed that 
an increase in the cross sectional area was associated with a significant decrease in ESS (p<0.00001).   
The results of the histopathological analysis are shown in section level in Table 4 and device 
level in Table 5. At 30-day histopathological assessment, the sections from the  scaffolded segments 
demonstrated minimal neointimal inflammation and minimal adventitial inflammation scores (Figure-
6). From all prepared histological sections(n=6), totally 72 struts were analysed. Around strut fibrin 
deposition was moderate to severe (mean score = 2.50 ± 0.24) and seen at 95.69 ± 2.47% of the 
evaluated struts.	Calcification was seen at the majority (mean= 53.28 ± 15.14%) of strut borders in all 
sections. The luminal surface showed incomplete endothelialization with frequent adherent luminal 
inflammatory cells. There was no luminal thrombus in the scaffolded vessels. 
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Discussion: 
In this exploratory study, we investigated the effect of scaffold design and strut profile of 
Absorb BVS on local hemodynamic microenvironment in healthy coronary arteries of porcine models. 
The main findings were as follows: 1) Thick rectangular non-streamlined struts of Absorb BVS caused 
recirculations and related low shear stress zones within the scaffolded luminal surface 2) The 
histopathological analysis showed minimal injury, minimal neointimal and adventitial inflammation 
at scaffolded segments 3) There was moderate to severe fibrin accumulation around the struts. 4) Re-
endothelialization of the analysed struts were not sufficient. 
The relation between stent/scaffold design and disrupted flow hemodynamics inducing 
neointimal tissue response and in-stent restenosis has been demonstrated previously (17). It’s obvious 
that it’s strenuous to evaluate this relationship through in vivo studies. Several in silico studies have 
demonstrated the impact of stent design on local hemodynamics after stent implantation(2). In the 
present study, the zig-zag hoop designed rings and thicker rectangular struts induced flow separations, 
stagnation zones and related lower shear stress zones in the vicinity of the struts in Absorb BVS.  
After constitution of a new luminal surface with implanted scaffold struts, shifted shear stress 
induces several patho-biological mechanisms within the vessel wall(18). The luminal surface coverage 
ratio, the curvature status of the implanted vessel segment, the design of the stent/scaffold, the strut 
geometry, the implantation process itself (implantation pressure, post-dilatation pressure, etc), 
embedment status of the stent struts are the factors for altered shear stress levels in scaffolded 
segment(18). Twenty-six percent luminal coverage ratio of Absorb BVS which is higher than its 
metallic equivalent, leads to higher endothelial denudation. This increased endothelial denudation with 
lower shear stress zones sets an susceptible environment for increased neointimal thickening through 
a continuous inflammation within the vessel wall (19 20). However, adequate inter-strut distance(1.0 
mm for Absorb BVS) enables the flow streamlines to recover their laminarity after the disruption 
around the rectangular thicker struts (21 22). This recovery should mitigate low shear stress levels on 
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the vessel wall. While the lower shear stress levels at besides of the struts and at inter-strut zones 
induce neointimal hyperplasia, the top of the struts induce less tissue hyperplasia due to increased shear 
stress levels at top of the struts(4).The histopathological analysis confirmed the variety in neointimal 
response at top of the struts and inter-strut zones due to the different levels of shear stress at top of 
struts and inter-strut areas. Both those mechanisms, adequate inter-strut distance and higher shear stress 
levels at top of the struts, with the anti-proliferative drug have counteracting effect for increased 
neointimal hyperplasia at follow up post implantation in Absorb BVS (4,23). 
 Inadequate re-endothelialization of the scaffold struts at 30-day histological analysis might 
be the result of several factors. The flow disruption in the scaffolded segment impairs nitric oxide 
production which has influence on physiologic endothelial homeostasis (24). Non-laminar flow at strut 
zones probably affected the endothelial migration at these areas. Another factor might be the increased 
anti-proliferative drug uptake by the vessel tissue due to the stagnation zones in the lower shear zones 
beside the struts. These stagnation zones can induce clotting process which affects the anti-proliferative 
drug kinetics. Increased fibrin accumulation around the struts within the histological specimens 
supports this pathomechanism in our study. In silico models approved the drug recycle between the 
thrombus and the lumen that prohibits the drug to pass from clot around the strut to the vessel wall and 
cause accumulation of the drug around the struts which can prevent the endothelial regeneration at 
strut zones (25). In the absence of an laminar shear stress, endothelial differentiation of several types 
of stem cells is deteriorated which also may help to explain the defective re-endothelialization of the 
struts at 30-day in our study (26,27).  
Limitations: 
There are some limitations in this research study. First, scaffold implantation was performed 
in healthy coronary vessels. Therefore, it was not possible to assess the impact of scaffold under-
expansion or of the composition of the underlying plaque on strut embedment which can influence the 
flow hemodynamics in scaffolded segments. Second, there was no comparator which would enable to 
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make a hypothesis for the hemo-rheologic properties of Absorb BVS. Third, in this exploratory study, 
at 30-day post-implantation, only two animals were sacrificed for histological analyses that was very 
limited for making a generalized comment for the histological analysis. Other animals will be 
euthanized at 180-day, 360-day and 720-day post-implantation for histological assessment.  
 
Conclusion: 
With its current design and strut profile, Absorb BVS induces fluctuations at ESS and related 
pathologic findings in scaffolded segments. The CFD examination should be handled delicately in 
order to improve the design characteristics of Absorb BVS in such a “hemo-compatible” way with 
reducing its strut thickness, converting the struts profile into a more streamlined form. 
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Figure 1: Absorb BVS 1.1 and the cross-section of Absorb BVS strut (A). OCT cross-section image 
of Absorb BVS. The strut of the Absorb BVS is rectangular and translucent(B). 
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Figure 2: Circumferential ESS values (median, maximum and minimum) over the luminal perimeter 
at 5º-subunits (sectors) counted from 3 o’clock. 
 
 
Figure 3: Histograms of ESS in scaffolded segments in Absorb BVS. “n” denotes the number of total 
ESS estimations at 5°-sectorial level. 
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Figure 4: Three-dimensional reconstruction of scaffolded coronary anatomy from the fusion of 
coronary angiograms and OCT data with the local ESS being portrayed in a color-coded map (dark 
blue indicates low ESS<1.0 Pa and aquamarine an ESS ≥1.0 Pa) for Absorb BVS (A and B). 
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Figure 5: Recirculation zones(red) were quantified based on the ESS and the centerline direction 
(proximal à distal). The red areas in the luminal surface are where the vectors of the ESS are pointing 
opposite (more than 90-degrees away from) the proximal-to-distal direction along the centerline (A). 
Rectangular cross-section induce recirculations upstream and downstream of the struts (B) 
 
 
 
 
Figure 6: Low (2x) (A) and High (20x) (B) power representative image of Absorb BVS. Images shown 
are stained by Movat (2x) (A) and Hematoxylin and eosin (20x) (B). All struts were morphologically 
identical as open acellular regions with well-defined borders. Neointimal hyperplasia was thicker at 
inter-strut zones than top of the struts (A,B) 
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Table-1: Description of Semi-Quantitative Histology Scores 
 
 
 
 
 
 
 
 
 
 
 
 
Attribute Score Description of Assigned Weight 
Injury Score 
(Using the method 
described by Schwartz 
et al14) 
0 Internal elastic lamina (IEL) intact, endothelium typically denuded, media may 
be compressed but not lacerated 
1 IEL lacerated, media typically compressed but not lacerated 
2 IEL lacerated, media visibly lacerated, external elastic lamina (EEL) intact but 
may be compressed 
3 EEL lacerated, typically large lacerations of media extending through EEL, coil 
wires sometimes residing in adventitia 
Neointimal 
Inflammation Score 
0 <25% struts with fewer than 10 inflammatory cells 
1 Up to 25% struts with greater than 10 inflammatory cells 
2 25-50% struts with greater than 10 inflammatory cells 
3 >50% struts with greater than 10 inflammatory cells 
4 2 or more struts with associated granulomatous inflammatory reactions 
Fibrin Score 0 No fibrin is appreciated (or only small strands) 
1 At least 25% of struts involving confluent fibrin that surrounds up to 25% of the 
strut circumference 
2 At least 50% of struts involving confluent fibrin that surrounds >25% of strut 
Fibrin Score circumference 
3 All struts with confluent fibrin surrounding >50% of strut circumference or 25-
50% of struts with confluent fibrin involving >25% of strut circumference with 
extension or bridging between struts 
Adventitial 
Inflammation Score 
0 No inflammation to minimal interspersed inflammatory cells anywhere in the 
adventitia 
1 Mild peripheral inflammatory infiltration or focally moderated in <25% of 
adventitial area 
2 Moderate peripheral inflammatory infiltration or focally marked in 25-50% of 
adventitial area 
3 Heavy peripheral inflammatory infiltration or focally marked in >50% of 
adventitial area 
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Table 2:	Inventory of scaffolds with implantation parameters. 
 
 
 
 
 
 
Table 3: The median ESS and lumen area in  OCT in scaffolded and non-scaffolded segment in OCT for each scaffold. The data are tabulated according 
to the ranking of ESS 
Scaffold Animal Median ESS 
(Q1-Q3)-Scaffolded 
segment  
(Pa) 
Median Lumen Area  
(Q1-Q3)- 
Scaffolded segment  
(mm2) 
Median Lumen area 
(Q1-Q3)- 
Distal non-scaffolded 
segment 
(mm2) 
Median Lumen area 
(Q1-Q3)- 
Proximal non-
scaffolded segment 
(mm2) 
ABSORB BVS-1 A 0.22 (0.12-0.39) 8.0 (6.94-8.36) 3.48 (3.38-3.61) 5.62 (5.17-6.68) 
ABSORB BVS-2 B 0.48 (0.27-0.82) 8.38 (7.93-8.71) 4.11 (3.94-4.41) 6.17 (5.32-6.38) 
ABSORB BVS-3 C 0.56 (0.33-0.87) 6.92 (6.81-7.14) 5.04 (4.11-5.15) 6.04 (4.89-7.05) 
ABSORB BVS-4 D 0.75 (0.51-1.10) 8.69 (8.55-8.93) 4.78 (4.52-5.10) 7.75 (7.57-8.09) 
ABSORB BVS-5 E 0.75 (0.40-1.35) 7.96 (7.70-8.36) 7.37 (6.72-7.89) 12.63 (11.14-14.24) 
ABSORB BVS-6 F 0.79 (0.43-1.29) 7.42 (7.24-7.51) 5.01 (4.21-7.23) 6.11 (5.68-6.41) 
 
Scaffold Animal Vessel Saffolde
d vessel 
segment 
Scaffold 
size 
(mm) 
Deployment 
balloon 
pressure(atm) 
Post-
dilatation 
balloon 
inflation 
pressure(atm) 
The diameter of the 
scaffold after 
implantation (in 
vitro) 
(mm) 
ABSORB BVS-1 Animal-A LCx Prox 3.0 x 18 7 7 3.0 
ABSORB BVS-2 Animal-B LCx Mid 3.0 x 18 7 8 3.0 
ABSORB BVS-3 Animal-C LCx Prox 3.0 x 18 7 8 3.0 
ABSORB BVS-4 Animal-D RCA Mid 3.0 x 15 7 14 3.3 
ABSORB BVS-5 Animal-E LAD Mid 3.0 x 18 7 7 3.0 
ABSORB BVS-6 Animal-F RCA Mid 3.0 x 18 7 7 3.0 
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Table-4: Histo-pathological analysis of 2 scaffolded vessel segments. Histological findings from the proximal, mid and distal segments of the scaffolded 
segments. 
Scaffold Ves. Sec. EEL 
Area 
IEL 
Area 
LA NA MA Ste. 
(%) 
NT 
(Mn) 
Inj. 
Sc 
Mal. 
 
(%) 
Fib 
(%) 
Fib 
Sc 
Gran 
(%) 
N.inf 
Sc 
Giant 
cell 
(%) 
RBC 
(%) 
End. 
cov. 
(%) 
Adv 
.Inf. 
Sc 
D30-2 LCx Prox 8.39 6.87 4.52 2.35 1.52 34.2 0.102 0.45 0.00 81.82 3 0.00 0 27.27 54.55 10 0 
D30-2 LCx Mid 8.32 7.01 4.58 2.43 1.31 34.7 0.126 0.92 0.00 100.0 3 0.00 0 8.33 75.00 20 0 
D30-2 LCx Dist 7.83 6.99 4.53 2.46 0.84 35.2 0.105 0.62 0.00 100.0 2 0.00 1 23.08 61.54 40 0 
D30-6 RCA Prox 7.96 6.97 4.29 2.68 0.99 38.5 0.130 0.00 0.00 100.0 2 0.00 0 41.67 41.70 99 0 
D30-6 RCA Mid 8.06 6.89 4.31 2.58 1.17 37.5 0.138 0.08 0.00 92.31 2 0.00 0 30.77 30.80 80 0 
D30-6 RCA Dist 8.87 7.53 4.28 3.25 1.34 43.2 0.217 0.45 0.00 90.00 3 0.00 0 63.64 45.45 90 0 
 
Ves : Vessel, Sec : Section,  EEL: External elastic lamina, IEL: internal elastic lamina, NA: Neointimal area, MA : Medial area, Ste: Stenosis, NT(Mn): 
Neointimal thickness(Mean), Inj Sc: Injury score, Mal: Malapposition, Fib: Fibrin, Gran : Granulocyte, N.inf Sc: Neointimal inflammation score, RBC : 
Red blood cell,  End. Cov. : Endothelial Coverage, Adv. Inf. Sc : Adventitial Inflammation score 
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Table-5a:  Morphometric analysis results from all sections (proximal, mid, distal) (mean ± SD) at light microscopy. 
 
 
 
 
 
Table-5b: Histologic analysis results from all sections(mean ± SD) at light microscopy. 
 
 
 
 
 
Table-5c: Histologic analysis of non-parametric scores from all sections (mean ± SD) at light microscopy. 
Mean Injury 
Score 
Mean Fibrin 
Score 
Neointimal Inflammation 
Score 
Adventitial Inflammation 
Score 
8.24±0.082 7.04±0.12 4.42±0.18 1.20±0.040 
 
EEL Area 
(mm2) 
IEL Area 
(mm2) 
Lumen Area 
(mm2) 
 
Medial Area 
(mm2) 
Neointimal 
Area (mm2) 
Stenosis 
(%) 
Neointimal 
Thickness (mm) 
8.24±0.082 7.04±0.12 4.42±0.18 1.20±0.040 2.62±0.30 37.19±3.53 0.14±0.036 
Strut 
Malapposition 
(%) 
Struts with 
Fibrin 
(%) 
Struts with 
Granuloma 
(%) 
Struts with 
Giant Cells 
(%) 
Struts with 
RBCs 
(%) 
Struts with 
Calcification 
(%) 
Endothelialization 
(%) 
8.24±0.082 7.04±0.12 4.42±0.18 1.20±0.040 2.62±0.30 37.19±3.53 0.14±0.036 
